LEXICON PHARMACEUTICALS, INC. Earnings Per Share Diluted

Quick Answer

LEXICON PHARMACEUTICALS, INC. reported Earnings Per Share Diluted of $0.14 (loss) per share for the year ending 2025.

  • LEXICON PHARMACEUTICALS, INC. showed an increase of +77.8% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from LEXICON PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), LEXICON PHARMACEUTICALS, INC.'s Earnings Per Share Diluted has grown by 88.0%.
  • Historical annual values: Fiscal year 2025: $0.14 (loss) per share | Fiscal year 2024: $0.63 (loss) per share | Fiscal year 2023: $0.80 (loss) per share | Fiscal year 2022: $0.62 (loss) per share | Fiscal year 2021: $0.60 (loss) per share | Fiscal year 2020: $0.53 (loss) per share | Fiscal year 2019: $1.16 per share | Fiscal year 2018: $1.14 (loss) per share | Fiscal year 2017: $1.17 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: